Nurix Therapeutics
Price & Volume
Stats
See moreOpen | $12.24 |
Previous Close | $12.09 |
Day Range | $11.13-$12.33 |
52W Range | $8.18-$29.56 |
Market Cap | $949.5M |
Shares Short | 14M |
Financials
See moreRevenue (12 Mos) | $56.4M |
Revenue Growth (YoY) | 11.3% |
Gross Profit (12 Mos) | -$184.8M |
Diluted EPS | -$2.60 |
News
See moreYahoo Finance • 3 days ago
Nurix Therapeutics price target lowered to $34 from $36 at H.C. Wainwright
Yahoo Finance • 4 days ago
Morgan Stanley lowers Nurix stock price target to $16 on higher spend
Yahoo Finance • 8 days ago
Goldman Sachs initiates Nurix stock with Buy rating, $182 price target
Yahoo Finance • 9 days ago
Nurix earnings beat by $0.19, revenue topped estimates
About
CEO | Dr. Arthur T. Sands M.D., Ph.D. |
Address | 1700 Owens Street, San Francisco, CA, United States, 94158 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 286 |
